Compare Mondaycom Ltd (MNDY) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mondaycom Ltd vs TransMedics Group Inc — how do they compare? Mondaycom Ltd trades at $92.25 (market cap $3.63B), while TransMedics Group Inc trades at $89.34 (market cap $3.02B). The key difference: Mondaycom Ltd is the larger of the two by market cap, and TransMedics Group Inc is trading nearer its 52-week high, Mondaycom Ltd nearer its low. Which is the better fit depends on your goals.
| MNDY | TMDX | |
|---|---|---|
Market Cap | $3.63B | $3.02B |
Sector | Technology | Technology |
52-Week High | $219.15 | $150.42 |
52-Week Low | $58.81 | $61.99 |
Enterprise Value | $2.80B | $3.41B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Monday.com (MNDY) trades at $85.95, down 1.74% amid mixed signals. The stock shows strong fundamentals with Q2 2026 EPS beating estimates at $1.48 versus $1.11 expected, marking the third consecutive quarterly beat. Revenue grew 22% year-over-year to $1.4 billion in 2026, though net profit margin compressed slightly to 8.87%. Technical indicators show neutral momentum with support at $84 and resistance at $87, while analyst consensus remains strongly bullish with a $113.38 price target representing 32% upside potential.
The outlook remains positive despite near-term volatility, driven by strong earnings momentum and AI product adoption. Key risks include slower revenue growth guidance for Q3 2026 and competitive pressures in the SaaS sector. Institutional sentiment remains constructive with 76% buy ratings, though recent price weakness reflects concerns about forward guidance amid broader market pressures on software stocks.
TransMedics Group (TMDX) trades at $87.02, down 2.62% on the day, amid mixed earnings performance. The stock shows strong profitability with a 22.69% net margin and 36.28% ROE, but recent quarters saw misses on EPS expectations. Technicals are bullish with moving averages supporting upside, while oscillators signal caution. Recent news highlights an ongoing legal investigation into fiduciary duties by company directors.
The outlook is cautiously optimistic with a consensus price target of $99.57 implying 14% upside, supported by bullish analyst ratings. Key risks include earnings volatility, rising costs impacting margins, and potential legal overhangs from the fiduciary investigation. Revenue growth remains a positive catalyst, but investors should monitor execution against future guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mondaycom Ltd
Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
